The randomized trials of breast cancer screening: what have we learned?
Authors:
- Robert A. SmithRSRobert A. Smith
- Stephen W. DuffySDStephen W. Duffy
- Rhian GabeRGRhian Gabe
- Laszlo TabarLTLaszlo Tabar
- Amy M.F. YenAYAmy M.F. Yen
- Tony H.H. ChenTCTony H.H. Chen
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 42 (5) , 793-806
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- On the efficacy of screening for breast cancerInternational Journal of Epidemiology, 2004
- The effect of tumor size and lymph node status on breast carcinoma lethalityCancer, 2003
- The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the diseaseEuropean Journal of Cancer, 2003
- The Gothenburg Breast Screening TrialCancer, 2003
- Re: All-Cause Mortality in Randomized Trials of Cancer ScreeningJNCI: Journal of the National Cancer Institute, 2002
- Breast cancer screening with mammographyThe Lancet, 1993
- Edinburgh trial of screening for breast cancer: mortality at seven yearsThe Lancet, 1990
- Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.BMJ, 1988
- Periodic breast cancer screening in reducing mortality from breast cancer1971
- Reproducibility of the technic of mammography (egan) for cancer of the breastThe American Journal of Surgery, 1965